🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to establish the tipranavir-ritonavir steady...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02251132
Study to characterize the effects of two dose combinations of Tipranavir (T...
Status
Terminated
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT02245438
The objective of this study was to characterize the effect of two dose comb...
Status
Completed
Location
Multiple Locations
Start Date
2001-11
Trial ID
NCT02249416
Treatments Being Tested
To determine the effect of steady-state tipranavir 500 mg/ritonavir 200 mg ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT02229760
Treatments Being Tested
This study was designed to provide early access to and evaluate the safety ...
Status
Approved For Marketing
Location
1182.70.127 Health Services Center, Inc.
Start Date
2004-12
Trial ID
NCT00097799
Treatments Being Tested
This study evaluated the safety and tolerability of tipranavir to improve t...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2004-05
Trial ID
NCT00144287
Treatments Being Tested
Study to characterise the effects of two dose combinations of tipranavir/ri...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT02251145
Objectives of the study were to evaluate the efficacy and safety of two dif...
Status
Terminated
Location
Multiple Locations
Start Date
1999-12
Trial ID
NCT02239835
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
1182.14.00001 Boehringer Ingelheim Investigational Site
Start Date
2003-11
Trial ID
NCT00076999
Treatments Being Tested
Primary: Sequentially determine the effects of three dose combinations of t...
Status
Completed
Location
Multiple Locations
Start Date
2001-02
Trial ID
NCT02251223